Annual Accounts Receivable
$763.00 K
+$763.00 K+100.00%
December 31, 2023
Summary
- As of February 23, 2025, SEEL annual accounts receivable is $763.00 thousand, with the most recent change of +$763.00 thousand (+100.00%) on December 31, 2023.
Performance
SEEL Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Accounts Receivable
N/A
June 30, 2024
Summary
- SEEL quarterly accounts receivable is not available.
Performance
SEEL Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
SEEL Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +100.0% | - |
| 3 y3 years | - | - |
| 5 y5 years | - | - |
SEEL Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | -100.0% | ||
| 5 y | 5-year | at high | -100.0% | ||
| alltime | all time | at high | -100.0% |
Seelos Therapeutics Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2024 | - | $968.00 K(+26.9%) |
| Dec 2023 | $763.00 K(>+9900.0%) | $763.00 K(+245.2%) |
| Sep 2023 | - | $221.00 K(-48.7%) |
| Jun 2023 | - | $431.00 K(-45.6%) |
| Mar 2023 | - | $793.00 K(>+9900.0%) |
| Dec 2022 | $0.00(-100.0%) | $0.00(-100.0%) |
| Sep 2016 | - | $398.00 K(-42.1%) |
| Jun 2016 | - | $687.00 K(-0.1%) |
| Mar 2016 | - | $688.00 K(+32.6%) |
| Dec 2015 | $519.00 K(-23.5%) | $519.00 K(-9.7%) |
| Sep 2015 | - | $575.00 K(-13.4%) |
| Jun 2015 | - | $664.00 K(+29.4%) |
| Mar 2015 | - | $513.00 K(-24.3%) |
| Dec 2014 | $678.00 K(+1049.2%) | $678.00 K(-18.2%) |
| Sep 2014 | - | $829.00 K(+1591.8%) |
| Jun 2014 | - | $49.00 K(-29.0%) |
| Mar 2014 | - | $69.00 K(+16.9%) |
| Dec 2013 | $59.00 K | $59.00 K(+68.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2013 | - | $35.00 K(-94.9%) |
| Jun 2013 | - | $681.00 K(+36.5%) |
| Mar 2013 | - | $499.00 K(-23.5%) |
| Dec 2012 | $652.00 K(+3004.8%) | $652.00 K(-82.9%) |
| Sep 2012 | - | $3.81 M(+726.6%) |
| Jun 2012 | - | $460.60 K(-48.4%) |
| Mar 2012 | - | $891.90 K(+4147.1%) |
| Dec 2011 | $21.00 K(-92.7%) | $21.00 K(-80.3%) |
| Sep 2011 | - | $106.70 K(+137.6%) |
| Jun 2011 | - | $44.90 K(-90.4%) |
| Mar 2011 | - | $469.10 K(+62.4%) |
| Dec 2010 | $288.80 K(-59.3%) | $288.80 K(-16.5%) |
| Sep 2010 | - | $345.90 K(-46.1%) |
| Jun 2010 | - | $641.70 K(+10.0%) |
| Mar 2010 | - | $583.60 K(-17.7%) |
| Dec 2009 | $708.90 K(>+9900.0%) | $708.90 K(>+9900.0%) |
| Dec 2008 | $0.00 | $0.00(-100.0%) |
| Jun 2002 | - | $155.10 K |
FAQ
- What is Seelos Therapeutics annual accounts receivable?
- What is the all time high annual accounts receivable for Seelos Therapeutics?
- What is Seelos Therapeutics annual accounts receivable year-on-year change?
- What is the all time high quarterly accounts receivable for Seelos Therapeutics?
What is Seelos Therapeutics annual accounts receivable?
The current annual accounts receivable of SEEL is $763.00 K
What is the all time high annual accounts receivable for Seelos Therapeutics?
Seelos Therapeutics all-time high annual accounts receivable is $763.00 K
What is Seelos Therapeutics annual accounts receivable year-on-year change?
Over the past year, SEEL annual accounts receivable has changed by +$763.00 K (+100.00%)
What is the all time high quarterly accounts receivable for Seelos Therapeutics?
Seelos Therapeutics all-time high quarterly accounts receivable is $3.81 M